William E. Schutzer

1.2k total citations
28 papers, 948 citations indexed

About

William E. Schutzer is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, William E. Schutzer has authored 28 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in William E. Schutzer's work include Receptor Mechanisms and Signaling (12 papers), Nitric Oxide and Endothelin Effects (6 papers) and Hormonal Regulation and Hypertension (5 papers). William E. Schutzer is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Nitric Oxide and Endothelin Effects (6 papers) and Hormonal Regulation and Hypertension (5 papers). William E. Schutzer collaborates with scholars based in United States and Czechia. William E. Schutzer's co-authors include Scott L. Mader, John F. Reed, Cynthia L. Bethea, Chrisana Gundlah, Melanie Pecins-Thompson, T Oyama, Jessie N. Lindsley, Sharon Anderson, Radko Komers and Zhaozeng Lu and has published in prestigious journals such as Journal of Clinical Investigation, Diabetes and Journal of the American Geriatrics Society.

In The Last Decade

William E. Schutzer

26 papers receiving 931 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William E. Schutzer United States 18 314 199 185 149 140 28 948
Rona Limor Israel 25 446 1.4× 376 1.9× 635 3.4× 207 1.4× 110 0.8× 62 2.1k
Huijie Ma China 21 300 1.0× 235 1.2× 83 0.4× 124 0.8× 132 0.9× 71 1.1k
Simonetta Tagliavini Italy 17 280 0.9× 105 0.5× 202 1.1× 157 1.1× 125 0.9× 62 957
Albert S. Chang United States 12 587 1.9× 123 0.6× 108 0.6× 96 0.6× 601 4.3× 16 1.4k
Linda Liliana Muñóz-Hernández Mexico 16 222 0.7× 224 1.1× 349 1.9× 89 0.6× 288 2.1× 39 1.3k
Anand R. Nair United States 22 334 1.1× 212 1.1× 167 0.9× 31 0.2× 63 0.5× 36 1.4k
Richard J. Koletsky United States 19 296 0.9× 380 1.9× 229 1.2× 45 0.3× 117 0.8× 37 1.3k
N S Jiang United States 19 266 0.8× 181 0.9× 242 1.3× 91 0.6× 73 0.5× 30 967
Katya B. Rubinow United States 17 170 0.5× 112 0.6× 298 1.6× 90 0.6× 44 0.3× 36 758

Countries citing papers authored by William E. Schutzer

Since Specialization
Citations

This map shows the geographic impact of William E. Schutzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Schutzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Schutzer more than expected).

Fields of papers citing papers by William E. Schutzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Schutzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Schutzer. The network helps show where William E. Schutzer may publish in the future.

Co-authorship network of co-authors of William E. Schutzer

This figure shows the co-authorship network connecting the top 25 collaborators of William E. Schutzer. A scholar is included among the top collaborators of William E. Schutzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William E. Schutzer. William E. Schutzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kozell, Laura B., Amy J. Eshleman, Katherine M. Wolfrum, et al.. (2025). Pharmacology of newly identified nitazene variants reveals structural determinants of affinity, potency, selectivity for mu opioid receptors. Neuropharmacology. 276. 110512–110512. 1 indexed citations
2.
Schutzer, William E., Laura B. Kozell, Amy J. Eshleman, et al.. (2025). Binding Affinity and Functional Activity of 24 Emerging Cannabinoids at the CB1 Receptor and Safety-Related Targets. Drug and Alcohol Dependence. 267. 111632–111632.
3.
Kozell, Laura B., Amy J. Eshleman, Katherine M. Wolfrum, et al.. (2024). Pharmacologic Characterization of Substituted Nitazenes at μ, κ, and Δ Opioid Receptors Suggests High Potential for Toxicity. Journal of Pharmacology and Experimental Therapeutics. 389(2). 219–228. 20 indexed citations
4.
Schutzer, William E., et al.. (2021). Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments. Drug and Alcohol Dependence. 227. 108974–108974. 29 indexed citations
5.
Eshleman, Amy J., Tracy L. Swanson, William E. Schutzer, et al.. (2020). Fentanyl but not Morphine Interacts with Nonopioid Recombinant Human Neurotransmitter Receptors and Transporters. Journal of Pharmacology and Experimental Therapeutics. 374(3). 376–391. 49 indexed citations
6.
Anderson, Sharon, T Oyama, Jessie N. Lindsley, et al.. (2011). 2-Hydroxyestradiol slows progression of experimental polycystic kidney disease. American Journal of Physiology-Renal Physiology. 302(5). F636–F645. 12 indexed citations
7.
Mader, Scott L., et al.. (2008). Program at Home: A Veterans Affairs Healthcare Program to Deliver Hospital Care in the Home. Journal of the American Geriatrics Society. 56(12). 2317–2322. 27 indexed citations
8.
Park, Jin Young, William E. Schutzer, Jessie N. Lindsley, et al.. (2007). p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levels. BMC Nephrology. 8(1). 12–12. 52 indexed citations
9.
Komers, Radko, William E. Schutzer, Hong Xue, et al.. (2007). Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats. Translational research. 150(6). 343–349. 24 indexed citations
10.
Schutzer, William E., Hong Xue, John F. Reed, & Scott L. Mader. (2006). Effect of Age on Vascular ss2-Adrenergic Receptor Desensitization Is Not Mediated by the Receptor Coupling to G i Proteins. The Journals of Gerontology Series A. 61(9). 899–906. 16 indexed citations
11.
Schutzer, William E., John F. Reed, & Scott L. Mader. (2004). Decline in caveolin-1 expression and scaffolding of G protein receptor kinase-2 with age in Fischer 344 aortic vascular smooth muscle. American Journal of Physiology-Heart and Circulatory Physiology. 288(5). H2457–H2464. 22 indexed citations
12.
Schutzer, William E. & Scott L. Mader. (2003). Age-related changes in vascular adrenergic signaling: clinical and mechanistic implications. Ageing Research Reviews. 2(2). 169–190. 41 indexed citations
13.
Komers, Radko, Jessie N. Lindsley, T Oyama, et al.. (2001). Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes. Journal of Clinical Investigation. 107(7). 889–898. 172 indexed citations
14.
Schutzer, William E., Val J. Watts, Justin Chapman, et al.. (2000). Viral‐Mediated Gene Delivery Of Constitutively Activated GΑS Alters Vasoreactivity. Clinical and Experimental Pharmacology and Physiology. 27(1-2). 9–13. 12 indexed citations
15.
Chapman, Joab, William E. Schutzer, Val J. Watts, & Scott L. Mader. (1999). Impaired Cholera Toxin Relaxation With Age in Rat Aorta. The Journals of Gerontology Series A. 54(4). B154–B159. 22 indexed citations
16.
Gundlah, Chrisana, Melanie Pecins-Thompson, William E. Schutzer, & Cynthia L. Bethea. (1999). Ovarian steroid effects on serotonin 1A, 2A and 2C receptor mRNA in macaque hypothalamus. Molecular Brain Research. 63(2). 325–339. 87 indexed citations
17.
Bethea, Cynthia L., Melanie Pecins-Thompson, William E. Schutzer, Chrisana Gundlah, & Zhaozeng Lu. (1998). Ovarian steroids and serotonin neural function. Molecular Neurobiology. 18(2). 87–123. 144 indexed citations
18.
Schutzer, William E. & Cynthia L. Bethea. (1997). Lack of ovarian steroid hormone regulation of norepinephrine transporter mRNA expression in the non-human primate locus coeruleus. Psychoneuroendocrinology. 22(5). 325–336. 17 indexed citations
19.
Schutzer, William E., et al.. (1996). Differential effect of trilostane on the progestin milieu in the pregnant mare. Reproduction. 107(2). 241–248. 17 indexed citations
20.
Schutzer, William E. & Donald W. Holtan. (1996). Steroid transformations in pregnant mares: Metabolism of exogenous progestins and unusual metabolic activity in vivo and in vitro. Steroids. 61(2). 94–99. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026